Replies to post #39136 on Cytodyn Inc (CYDY)

[Suvorov]

Sorry to break your bubble, but there is no such thing as a 'non dilutive financing' unless it is a debt financing, a JV or a takeover.

Every equity financing is, by definition, dilutive.

And with CYDY with no cash flow, dilutive financing will be here for some time to come.

[I_luv_cydy]

I agree with Saltz. How many positive PRs have we had the past few months where the SP did nothing and in some cases even went lower. And of course the PR needs improvement so nothing has changed.
I'm long and strong but expect not much price movement today.

[Blueheel1]

I agree with this. I have been doing my part trying to get others to buy into the story – – a particularly savvy investment friend of mine told me that “most companies on the OTC fail due to a lack of funding - and asked how I knew this company wouldn’t run out of money”. I told him I was confident, but it made me think.

And that’s about it – – the market is still looking at this as a completely binary play, assigning a decent probability to this running out of money. It’s interesting, because Pestell mentioned that the HIV side had been “de-risked”. So, perhaps much of the science has been de-risked, but financially de-risking will only occur with a more viable and nondilutive source of capital.

And that explains to me why even the best scientific PRs have no impact on the SP.